Nasal Desmopressin Recall Affects Availability Through 2023

Nasal Desmopressin Recall Affects Availability Through 2023

286243

Nasal Desmopressin Recall Affects Availability Through 2023

An internal investigation conducted by Ferring Pharmaceuticals into its recently recalled desmopressin nasal spray formulations found an issue with the tightness of the bottle seal. Measures taken to prevent recurrence of the issue will affect the availability of the products through at least 2023. The company announced in a press release its plans to install a new production line to prevent the bottle seal issue from occurring again, with the production of its desmopressin products expected to…

You must be logged in to read/download the full post.